Stanford Medicine and LEADOPTIK Collaborate on AI Imaging for Lung Biopsies

Stanford Medicine and LEADOPTIK have announced a research collaboration to explore the use of AI-enhanced real-time optical imaging in lung biopsy procedures. Announced in a press release, this partnership aims to improve lesion assessment and biopsy accuracy through high-resolution imaging, contributing to the development of smart tools for clinical decision-making.

The collaboration will integrate real-time optical imaging into biopsy workflows, providing immediate insights at the point of care. This approach is expected to enhance the understanding of tissue microstructure, supporting future advancements in AI-driven analysis. Stanford Medicine's Interventional Pulmonology Program will lead the evaluation of this technology's potential in refining sample collection strategies and improving patient outcomes.

LEADOPTIK, known for its real-time optical imaging technology, aims to validate its imaging solutions through this partnership. The collaboration will focus on refining advanced analytics applications, further supporting the clinical adoption of intelligent imaging solutions.